The Manufacturers Life Insurance Company increased its stake in National Health Investors, Inc. (NYSE:NHI – Free Report) by 4.1% during the 2nd quarter, Holdings Channel reports. The fund owned 24,051 shares of the real estate investment trust’s stock after purchasing an additional 950 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in National Health Investors were worth $1,629,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of the stock. Vanguard Group Inc. raised its stake in shares of National Health Investors by 0.7% in the first quarter. Vanguard Group Inc. now owns 6,189,864 shares of the real estate investment trust’s stock valued at $388,909,000 after acquiring an additional 43,520 shares in the last quarter. Lasalle Investment Management Securities LLC raised its stake in shares of National Health Investors by 8.4% in the first quarter. Lasalle Investment Management Securities LLC now owns 508,035 shares of the real estate investment trust’s stock valued at $31,920,000 after acquiring an additional 39,554 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its stake in shares of National Health Investors by 16.0% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 472,959 shares of the real estate investment trust’s stock valued at $32,034,000 after acquiring an additional 65,104 shares in the last quarter. Land & Buildings Investment Management LLC raised its stake in shares of National Health Investors by 4.6% in the second quarter. Land & Buildings Investment Management LLC now owns 417,834 shares of the real estate investment trust’s stock valued at $28,300,000 after acquiring an additional 18,232 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its stake in shares of National Health Investors by 4.6% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 197,863 shares of the real estate investment trust’s stock valued at $12,432,000 after acquiring an additional 8,642 shares in the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.
National Health Investors Stock Performance
Shares of NHI stock opened at $78.64 on Friday. The stock’s 50-day moving average is $80.09 and its two-hundred day moving average is $70.95. The firm has a market cap of $3.41 billion, a price-to-earnings ratio of 25.78, a PEG ratio of 8.86 and a beta of 1.04. National Health Investors, Inc. has a 1 year low of $48.51 and a 1 year high of $86.13. The company has a debt-to-equity ratio of 0.91, a quick ratio of 10.27 and a current ratio of 10.27.
National Health Investors Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Friday, September 27th will be issued a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.58%. The ex-dividend date of this dividend is Friday, September 27th. National Health Investors’s dividend payout ratio is currently 118.03%.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on NHI. Bank of America assumed coverage on National Health Investors in a research note on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price objective on the stock. StockNews.com upgraded National Health Investors from a “hold” rating to a “buy” rating in a research note on Thursday, August 8th. Wells Fargo & Company cut National Health Investors from an “overweight” rating to an “equal weight” rating and raised their price target for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. Finally, Truist Financial raised their price target on National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research note on Friday, August 30th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, National Health Investors has a consensus rating of “Moderate Buy” and an average price target of $73.29.
Check Out Our Latest Stock Analysis on NHI
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Recommended Stories
- Five stocks we like better than National Health Investors
- Consumer Staples Stocks, Explained
- MercadoLibre Targets Double-Digit Upside with Argentina Boom
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Domino’s Pizza Stock Delivers: A Hot Buy for Growth Investors
- There Are Different Types of Stock To Invest In
- 3 Small-Cap Stocks Ready to Deliver Significant Growth
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI – Free Report).
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.